13D/13G Filings - Orphazyme A/S

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-10
07:06 am
Sale
2022-12-31 13G Orphazyme A/S
ORPHY
LSP V Cooperatieve U.A. 2,426,711
6.900%
-169,450decrease
(-6.53%)
Filing
History
2022-02-03
4:16 pm
Sale
2021-12-31 13G Orphazyme A/S
ORPHY
LSP V Cooperatieve U.A. 2,596,161
7.000%
-114,668decrease
(-4.23%)
Filing
History
2021-02-11
4:16 pm
Purchase
2020-12-31 13G Orphazyme A/S
ORPHY
SUNSTONE LIFE SCIENCE VENTURES FUND II K/S 1,789,845
5.200%
1,789,845increase
(New Position)
Filing
History
2021-02-09
5:00 pm
Purchase
2020-12-31 13G Orphazyme A/S
ORPHY
Cooperatieve AESCAP Venture I U.A. 1,758,105
5.100%
1,758,105increase
(New Position)
Filing
History
2021-02-08
4:15 pm
Purchase
2020-12-31 13G Orphazyme A/S
ORPHY
LSP V Cooperatieve U.A. 2,710,829
7.800%
2,710,829increase
(New Position)
Filing
History